| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | SENATE DOCKET, NO. 2321 FILED ON: 1/20/2023 |
|---|
| 3 | 3 | | SENATE . . . . . . . . . . . . . . No. 1240 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | Brendan P. Crighton |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act to educate on prescription opioids. |
|---|
| 13 | 13 | | _______________ |
|---|
| 14 | 14 | | PETITION OF: |
|---|
| 15 | 15 | | NAME:DISTRICT/ADDRESS :Brendan P. CrightonThird Essex 1 of 1 |
|---|
| 16 | 16 | | SENATE DOCKET, NO. 2321 FILED ON: 1/20/2023 |
|---|
| 17 | 17 | | SENATE . . . . . . . . . . . . . . No. 1240 |
|---|
| 18 | 18 | | By Mr. Crighton, a petition (accompanied by bill, Senate, No. 1240) of Brendan P. Crighton for |
|---|
| 19 | 19 | | legislation to educate on prescription opioids. Mental Health, Substance Use and Recovery. |
|---|
| 20 | 20 | | The Commonwealth of Massachusetts |
|---|
| 21 | 21 | | _______________ |
|---|
| 22 | 22 | | In the One Hundred and Ninety-Third General Court |
|---|
| 23 | 23 | | (2023-2024) |
|---|
| 24 | 24 | | _______________ |
|---|
| 25 | 25 | | An Act to educate on prescription opioids. |
|---|
| 26 | 26 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 27 | 27 | | of the same, as follows: |
|---|
| 28 | 28 | | 1 SECTION 1. Chapter 94C of the General Laws is hereby amended by inserting after |
|---|
| 29 | 29 | | 2section 18C the following new section:- |
|---|
| 30 | 30 | | 3 Section 18D. In the event that a practitioner issues a prescription for an opioid contained |
|---|
| 31 | 31 | | 4in Schedule II of section 3, the practitioner shall also provide education on the potential adverse |
|---|
| 32 | 32 | | 5risks of the prescription opioid, including the need to also obtain an opioid overdose reversal |
|---|
| 33 | 33 | | 6agent, such as naloxone, if one of the following conditions is present: (i) the patient is prescribed |
|---|
| 34 | 34 | | 7an opioid which individually or in aggregate with other medications is more than equal to 50 |
|---|
| 35 | 35 | | 8morphine milligram 7 equivalents per day; (ii) the patient is prescribed any dose of an opioid |
|---|
| 36 | 36 | | 9when a benzodiazepine has been prescribed in the past 30 days or will be prescribed at the visit; |
|---|
| 37 | 37 | | 10or (iii) the patient has a prior history of opioid use disorder or overdose or has a history of |
|---|
| 38 | 38 | | 11substance use disorder. If the practitioner does not provide this education on an opioid antagonist |
|---|
| 39 | 39 | | 12at the time said prescription for an opioid is issued, the practitioner shall document in the |
|---|
| 40 | 40 | | 13patient’s medical record why an opioid antagonist was not appropriate for the patient. |
|---|